Crossmark

Integrating network pharmacology and experimental validation deciphers the improving effect and mechanisms of Shenwu Yizhi capsule on cognitive impairment in vascular dementia rats

Crossref DOI link: https://doi.org/10.1007/s11011-025-01690-y

Published Online: 2025-09-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhen, Yilan https://orcid.org/0000-0002-9357-8375
Wang, Xueqing

Niu, Jingwen

Chen, Daokang

He, Cunbao https://orcid.org/0009-0002-6550-2987
Zhu, Guoqi

Ban, Wenming
Funding

Funding for this research was provided by:

Natural Science Foundation of the Anhui Education Department (RZ2300001709)

Talent Support Program of Anhui University of Traditional Chinese Medicine (DT2300000178)

Research Funds of the Fuyang Municipal Health Commission (FY2021-094)
License Information

Text and Data Mining valid from 2025-09-06

Version of Record valid from 2025-09-06
More Information

Article History

Received: 16 January 2025

Accepted: 31 July 2025

First Online: 6 September 2025

Declarations

:

: The experimental protocols were approved by the Ethics Committee of Anhui University of Chinese Medicine (Approval ID: AHUCM-rats-2023002).

: The authors declare no competing interests.

Document is current

Any future updates will be listed below